The recent outbreak of COVID-19 has shocked everyone. Community screening is the most important aspect to reduce this disease spread. Identifying likely infected people correctly helps in controlling the spread well. Among the most common symptoms seen in likely COVID positive patients are fever, dry throat and possible sneezing. According to CDC, all visitors to a hospital, a public place or any other institution should be passively screened for symptoms of fever and acute respiratory illness before entering any facility.
While in Switzerland, infrared forehead thermometers are used to measure the temperature of people in airports, hospitals and other public places – and is referred to as thermal screening. This method of measuring the temperature is prone to manual errors, time consuming and does not scale for large population. It is also risky to the security personnel who perform the screening. Just measuring increased temperature of the person is also not a sufficient signal of COVID19 infection.
Meditherma has recently developed an AI-enabled solution for automatic detection of Fever and COVID19 respiratory symptoms. It is aimed towards enabling automated screening of groups of people to detect likely COVID19 infected people by checking for fever plus associated respiratory diseases. This solution uses Meditherma’s most awarded novel AI solution called Inralytix™ (Artificial Intelligence Algorithms over thermal images). The above solution can be monitored automatically by a simply skilled health-worker, thus reducing the pressure on clinical testing at public places.